Latest Stock Buy or Sell?
Make More Informed Decisions!

Today, The Panic-Proof Portfolio (Stockchase Research) and David Fingold commented about whether TSM-N, KYCCF-5, SKFOF-OTC, F-N, AAPL-Q, BABA-N, SKFOF-OTC, 7741-JP, KEYS-N, PINS-N, PFE-N, ZTS-N, BLK-N, 7741-JP, STX-Q, PGR-N, APHA-T, INTC-Q, TSN-N, KBH-N, OGI-T are stocks to buy or sell.

premium

This is a Panic-proof Portfolio opinion which is available only for Premium members

Curated by Michael O'Reilly since 2020.
1550+ opinions with 4.81 rating (one of the best performing expert).

TOP PICK
Stockchase Research Editor: Michael O'Reilly OGI is a cannabis producer serving the Canadian market. Recent earnings disappointed on the revenue side (down by 23%), but management is noting that adult recreational use is up 30% over the year. The company is now producing positive cash flows (in 2 of the last 3 quarters), building its cash position, and is successfully paying off debt. We would buy this with a stop-loss at $1.40, looking to achieve $3.50 -- upside potential of 55%. Yield 0% (Analysts’ price target is $3.43)
Other Agricultural Products
premium

This is a Panic-proof Portfolio opinion which is available only for Premium members

Curated by Michael O'Reilly since 2020.
1550+ opinions with 4.81 rating (one of the best performing expert).

TOP PICK
KB Home
Stockchase Research Editor: Michael O'Reilly KBH is a US homebuilder. Recently reported revenues were disappointing -- down over 23% -- but sales prices were 5% higher backed by the expectation of continued low interest rates. Overall, EPS of $1.12 came in $0.18 higher than analyst expectations. The company reported orders volumes increased 50% putting order backlogs at 15 year highs. It trades at 10x earnings compared to sector averages over 34x -- making this good value here. It pays a small dividend, backed by a 13% payout ratio. We would buy this with a stop-loss at $27, looking to achieve $44 -- over 22% upside. Yield 1.71% (Analysts’ price target is $43.13)
contractors
premium

This is a Panic-proof Portfolio opinion which is available only for Premium members

Curated by Michael O'Reilly since 2020.
1550+ opinions with 4.81 rating (one of the best performing expert).

TOP PICK
Tyson Foods Inc.
Stockchase Research Editor: Michael O'Reilly TSN is the world's largest meat producer, selling to over 140 countries. The pandemic caused operational issues with outbreaks at its numerous facilities, but those have been virtually all resolved. It pays a great dividend, backed by a 29% payout ratio. It trades at 13x earnings, compared to a sector average of 43x, making it good value here. We would buy this with a $50 stop-loss, looking to achieve $80 -- potential upside of over 22%. Yield 2.78% (Analysts’ price target is $80.00)
food processing
premium

This is a Panic-proof Portfolio opinion which is available only for Premium members

Curated by Michael O'Reilly since 2020.
1550+ opinions with 4.81 rating (one of the best performing expert).

PAST TOP PICK
Intel
(A Top Pick Nov 24/20, Up 23.1%)Stockchase Research Editor: Michael O'Reilly Our PAST TOP PICK with INTC has achieved our $58 objective. To be disciplined, we recommend covering 50% of the position. We would also recommend trailing up the stop to $47 -- right around the initial suggested entry level.
computer parts mnfctr
premium

This is a Panic-proof Portfolio opinion which is available only for Premium members

Curated by Michael O'Reilly since 2020.
1550+ opinions with 4.81 rating (one of the best performing expert).

PAST TOP PICK
Aphria Inc
(A Top Pick Dec 17/20, Up 24.8%)Stockchase Research Editor: Michael O'Reilly Our PAST TOP PICK with APHA has achieved our $12.50 objective. To be disciplined, we recommend covering 50% of the position. We also recommend trailing up the stop to $8.00.
agriculture
COMMENT
How will the pandemic change your investing style? Not likely to change his strategy. These disruptions happen. It's been hard on people, but there have been pandemics before, and there will be again. Currency, interest rates, and commodity prices all go up and down. Choose companies that have resilience, with a business model that can survive adversity. He selects quality companies. Investors will have to spend more time doing due diligence.
Unknown
COMMENT
Science is telling us there may be a worse virus to come. The 1918 influenza epidemic had an impact on the economy. Influenza in the 1950s and again in the 1968 recession both affected economic activity. Businesses need to be able to adapt. For example, a media company's business model is more resilient since people can work from home. This allows these businesses to take market share. There are always concerns: SARS, Covid, terrorism, recessions.
Unknown
PARTIAL SELL
Very fine company. One of the best property and casualty companies in the world. Relatively resilient, defensive business model. Long-term, he recommends it. But for short and medium performance, we're exiting a recession, so it makes sense to put more capital into cyclicals.
insurance
DON'T BUY
Seagate Technology
Hard drives refuse to die. Hoya is the only supplier of glass platters, so that's where he's invested. Hard drives will be transitioning from aluminum to glass over the next 5 years.
computer software / processing
BUY
Hoya Corporation
Hard drives refuse to die. Hoya is the only supplier of glass platters, so that's where he's invested. Hard drives will be transitioning from aluminum to glass over the next 5 years.
Healthcare
BUY
Blackrock Inc.
Likes it. One of the largest suppliers in the world of index funds. They have scale. One of the few parts of asset management that's growing. Compelling management fees.
Financial Services
PARTIAL SELL
Zoetis Inc
Likes it in the long term. He's taken some profit. Short-term concern is that a lot of people bought pandemic companion animals, so 2020 was a really good year, and it's going to be hard to top 2020.
Consumer Products
DON'T BUY
Pfizer Inc

An area that's started to act better recently. Well managed. But doesn't understand what the catalysts are. Doesn't find it compelling. Consider the picks and shovels instead, like Agilent or Danaher, who benefit from growth in everyone's pipeline.

biotechnology / pharmaceutical
DON'T BUY
Pinterest

Likes the product. Concern is one of scale. How much bigger can it be, and how compelling is the product? Likes the cyclical aspect of increased ad revenues. Better ways to get access to those revenues, such as Google or a media content library owner.

Technology
PAST TOP PICK

(A Top Pick Dec 02/19, Up 44%) Very fine company. Exited for better ideas. He would buy it again. They're very exposed to the 5G market, and he chose to own Teradyne instead.

0